OGT Launches ISCA-endorsed CytoSure™ aCGH Arrays for Detecting Disease and Syndrome-Related Aberrations
Product News Feb 04, 2010
Oxford Gene Technology (OGT) has introduced three new CytoSure™ ISCA aCGH arrays to meet all resolution, multiplexing and budget requirements.
Designed in collaboration with the International Standard Cytogenomic Array (ISCA) Consortium, the 8 x 60k, 4 x 180k and 4 x 44k CytoSure ISCA formats, provide powerful arrays focusing on disease and syndrome-associated genome regions, in addition to offering whole genome coverage.
Using a proprietary 60-mer probe design and multiple rounds of optimization, the CytoSure ISCA aCGH arrays ensure reliability and confident detection of genetic aberrations with high signal-to-noise ratios.
Each CytoSure array is accompanied with the user-centric CytoSure Interpret analysis software. This easy-to-use tool ensures translation of data into meaningful results. The features include the “Accelerate” workflow, for customizable automation of routine data analysis, and full integration with existing data and publicly available cytogenetics databases including the Database of Genomic Variants (DGV, Canada) and DECIPHER (Sanger Institute, UK).
In addition to CytoSure ISCA arrays and Interpret software, the CytoSure aCGH product line includes a range of high quality arrays covering single disorders through to entire syndrome spreads, as well as SciGene automation instrumentation (now distributed in Europe by OGT). As a result, OGT’s comprehensive products and services are the ideal solution for running oligo aCGH in the laboratory.